This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PET
- Utility of Amino Acid PET in the Differential Diagnosis of Recurrent Brain Metastases and Treatment-Related Changes: A Meta-analysis
- Amino Acid PET in Neurooncology
- Amino Acid PET in Neurooncology
- Diagnostic value of PET with different radiotracers and MRI for recurrent glioma: a Bayesian network meta-analysis
- 11C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
- Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
- Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature
- Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and 11C-Methionine PET/CT for Differentiation of Tumor Recurrence from Radiation Injury in Patients with High-Grade Gliomas
- Prognostic Value of the Metabolic and Volumetric Parameters of 11C-Methionine Positron-Emission Tomography for Gliomas: A Systematic Review and Meta-Analysis
- Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis
- Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC--Preliminary Results
- 18F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis
- Although Non-diagnostic Between Necrosis and Recurrence, FDG PET/CT Assists Management of Brain Tumours After Radiosurgery
- Clinical Impact of Amino Acid PET in Gliomas
- A Meta-Analysis on the Diagnostic Performance of 18F-FDG and 11C-Methionine PET for Differentiating Brain Tumors
- 18F-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment
- Radiolabeled Amino Acids for Oncologic Imaging
- PET Findings of Intramedullary Tumors of the Spinal Cord Using [18F] FDG and [11C] Methionine
- Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
- 11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI
- Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis
- Accurate Differentiation of Recurrent Gliomas from Radiation Injury by Kinetic Analysis of {alpha}-11C-Methyl-L-Tryptophan PET
- Multimodality Assessment of Brain Tumors and Tumor Recurrence
- Examination of 11C-Methionine Metabolism by the Standardized Uptake Value in the Normal Brain of Children
- Evaluation of the Accumulation of 11C-Methionine with Standardized Uptake Value in the Normal Brain
- MR Spectroscopy in Radiation Injury
- Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
- Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
- Reply: Brain SPECT by 99mTc-Tetrofosmin for the Differentiation of Tumor Recurrence from Radiation Injury
- Brain SPECT by 99mTc-Tetrofosmin for the Differentiation of Tumor Recurrence from Radiation Injury